Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hospitalization in Those With, Without Diabetes

Diabetes Care; ePub 2017 Nov 17; Burrows, et al

Rates of hospitalization for cardiovascular (CV) disease declined significantly in people with and without diabetes in a study involving individuals with various CV conditions. Still, rates remained higher in those with diabetes. Investigators looked at discharge data of participants with acute coronary syndrome (ACS), cardiac dysrhythmia, heart failure, hemorrhagic stroke, or ischemic stroke, as well as diabetes. They calculated hospitalization rates using estimates from people with and without diabetes from the National Health Interview Survey. Among the results:

  • Age-adjusted hospitalization rates declined 5%/year between 1998 and 2014 in patients with diabetes.
  • Rates also declined annually for cardiac dysrhythmia (1%), heart failure (4%), hemorrhagic stroke (1%), and ischemic stroke (3%) in those with diabetes.
  • Declines were similar in patients without diabetes, except for dysrhythmia, where the drop was not statistically significant.
  • By 2014, hospitalization rates in patients with diabetes remained 2 to 4 times higher than those without diabetes.
  • The widest gap occurred in those with heart failure.

Citation:

Burrows N, Li Y, Gregg E, Geiss L. Declining rates of hospitalization for selected cardiovascular disease conditions among adults aged ≥35 years with diagnosed diabetes, U.S., 1998–2014. [Published online ahead of print November 17, 2017]. Diabetes Care. doi:10.2337/dc17-1259.

This Week's Must Reads

Cochrane on Clinician-Focused Weight Loss Tactics, Cochrane; 2017 Nov 30; Flodgren, et al

Cochrane on Delaying Diabetes in People with IGT, Cochrane; 2017 Dec 5; Hemmingsen, et al

Consider Using This Risk Tool to Predict T2D Risk, Diabetes Care; ePub 2017 Dec 1; Bergmark, Bhatt, et al

Dysglycemia Cause in Overweight Adults, Teens, Diabetes Care; ePub 2017 Nov 28; Chen, et al

FDA Approves Semaglutide for Type 2 Diabetes, Novo Nordisk news release; 2017 Dec 5

Must Reads in Diabetes

Cochrane on Delaying Diabetes in People with IGT, Cochrane; 2017 Dec 5; Hemmingsen, et al

Consider Using This Risk Tool to Predict T2D Risk, Diabetes Care; ePub 2017 Dec 1; Bergmark, Bhatt, et al

Dysglycemia Cause in Overweight Adults, Teens, Diabetes Care; ePub 2017 Nov 28; Chen, et al

FDA Approves Semaglutide for Type 2 Diabetes, Novo Nordisk news release; 2017 Dec 5

Hospitalization in Those With, Without Diabetes, Diabetes Care; ePub 2017 Nov 17; Burrows, et al